Family Spirit Strengths

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age14+
SponsorJohns Hopkins Bloomberg School of Public Health

About this trial

This project addresses the disproportionate morbidity and mortality associated with mental and behavioral health problems in American Indian and Alaska Native communities. Access to culturally competent and effective behavioral health services is limited in many of these communities. The investigators aim to address this gap by testing the effectiveness of a trans-diagnostic secondary prevention program, Family Spirit Strengths (FSS) that can be embedded within home visiting services. The FSS program is a skills-based program that incorporates elements of evidence-based practice, the Common Elements Treatment Approach (CETA), and materials informed and developed based on an Indigenous advisory group. The FSS program aims to help participants build self-efficacy and coping skills, as well as build stronger connections to others, the participants' community, and cultural resources. The investigators will use a randomized controlled trial, whereby half of the participants will receive FSS and the other half will receive an evidence-based nutrition education program. The investigators' study is grounded in participatory processes and led by a team of Indigenous and allied researchers.

Eligibility criteria

Qualifiers

Self-identify as female; and

Pregnant or be a primary caregiver of a child that is 24 months or younger; and

14 years or older at time of enrollment; and

Report a family history of high-risk substance use and/or report high-risk levels of personal substance use; and

Disqualifiers

Profound disability that limits the ability to participate in assessments or interventions; and

Unlikely to be residing in or near the research service area for the next 6 months.

Trial design

Treatments tested in this trial

  • Family Spirit Strengths (FSS)
  • Family Spirit Nurture

Treatment groups

188 Participants
are divided into 2 treatment groups